According to filings with the U.S. Securities and Exchange Commission, OnCall Health dba Cayaba Care is raising up to $9,430,031.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Daphne…
According to filings with the U.S. Securities and Exchange Commission, Fiduciary Exchange is raising up to $12,012,115.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Rich Romano played a…
According to filings with the U.S. Securities and Exchange Commission, Myota is raising up to $2,500,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, James Walker played a key…
According to filings with the U.S. Securities and Exchange Commission, Cornelis Networks is raising up to $45,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Philip Murphy played a…
According to filings with the U.S. Securities and Exchange Commission, Quaint Oak Bank is raising $1,462,373.00 in new funding. About Quaint Oak Bank: Quaint Oak Bancorp, Inc. operates as the holding company for Quaint Oak…
Malvern, PA — Tripled Shredded Capital LLC dba Mulch & More has secured $1,810,000.00 in new commercial financing for expansion opportunities in Malvern. According to the company website, Welcome to Mulch & More, your local…
According to filings with the U.S. Securities and Exchange Commission, Mineralys Therapeutics is raising $120,000,000.00 in new funding. About Mineralys Therapeutics: Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of…
According to filings with the U.S. Securities and Exchange Commission, Larimar Therapeutics is raising $172,500,000.00 in new funding. About Larimar Therapeutics: Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases…
According to filings with the U.S. Securities and Exchange Commission, Immunome is raising $230,000,000.00 in new funding. About Immunome: Immunome is a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies. Our portfolio…
According to filings with the U.S. Securities and Exchange Commission, Partium is raising up to $18,455,195.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Philipp Descovich played a key…